Correlation Between GH Research and Eliem Therapeutics
Can any of the company-specific risk be diversified away by investing in both GH Research and Eliem Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GH Research and Eliem Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GH Research PLC and Eliem Therapeutics, you can compare the effects of market volatilities on GH Research and Eliem Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GH Research with a short position of Eliem Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of GH Research and Eliem Therapeutics.
Diversification Opportunities for GH Research and Eliem Therapeutics
-0.16 | Correlation Coefficient |
Good diversification
The 3 months correlation between GHRS and Eliem is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding GH Research PLC and Eliem Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eliem Therapeutics and GH Research is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GH Research PLC are associated (or correlated) with Eliem Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eliem Therapeutics has no effect on the direction of GH Research i.e., GH Research and Eliem Therapeutics go up and down completely randomly.
Pair Corralation between GH Research and Eliem Therapeutics
Given the investment horizon of 90 days GH Research PLC is expected to generate 0.99 times more return on investment than Eliem Therapeutics. However, GH Research PLC is 1.01 times less risky than Eliem Therapeutics. It trades about 0.14 of its potential returns per unit of risk. Eliem Therapeutics is currently generating about -0.29 per unit of risk. If you would invest 806.00 in GH Research PLC on August 29, 2024 and sell it today you would earn a total of 104.00 from holding GH Research PLC or generate 12.9% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 90.91% |
Values | Daily Returns |
GH Research PLC vs. Eliem Therapeutics
Performance |
Timeline |
GH Research PLC |
Eliem Therapeutics |
GH Research and Eliem Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with GH Research and Eliem Therapeutics
The main advantage of trading using opposite GH Research and Eliem Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GH Research position performs unexpectedly, Eliem Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eliem Therapeutics will offset losses from the drop in Eliem Therapeutics' long position.GH Research vs. Molecular Partners AG | GH Research vs. MediciNova | GH Research vs. Anebulo Pharmaceuticals | GH Research vs. Champions Oncology |
Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |